Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01VDI
|
|||
| Former ID |
DIB015730
|
|||
| Drug Name |
AVI-5126
|
|||
| Synonyms |
Resten-CP; NeuGene (CABG), AVI
Click to Show/Hide
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Coronary artery disease [ICD-11: BA80; ICD-10: I25.1, I25.4] | Phase 2 | [1] | |
| Company |
AVI BioPharma
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00451256) Safety and Efficacy Study of AVI-5126 When Used on Vein Grafts Before Use in Heart by-Pass Graft Surgery (CABG). U.S. National Institutes of Health. | |||
| REF 2 | Efficacy of a phosphorodiamidate morpholino oligomer antisense compound in the inhibition of corneal transplant rejection in a rat cornea transplant model. J Ocul Pharmacol Ther. 2012 Apr;28(2):194-201. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.